BillionToOne, Inc. Class A Common Stock (BLLN) - Total Liabilities
Based on the latest financial reports, BillionToOne, Inc. Class A Common Stock (BLLN) has total liabilities worth $195.11 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
BillionToOne, Inc. Class A Common Stock - Total Liabilities Trend (2023–2025)
This chart illustrates how BillionToOne, Inc. Class A Common Stock's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of BillionToOne, Inc. Class A Common Stock to evaluate short-term liquidity relative to the company's equity base.
BillionToOne, Inc. Class A Common Stock Competitors by Total Liabilities
The table below lists competitors of BillionToOne, Inc. Class A Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hanjaya Mandala Sampoerna Tbk PT
JK:HMSP
|
Indonesia | Rp21.48 Trillion |
|
Electric Connector Technology Co Ltd
SHE:300679
|
China | CN¥2.30 Billion |
|
Wistron NeWeb Corp
TW:6285
|
Taiwan | NT$51.52 Billion |
|
Ultra Clean Holdings Inc
NASDAQ:UCTT
|
USA | $1.15 Billion |
|
AIXTRON SE (UNSP.ADR/2)
F:AIX2
|
Germany | €162.80 Million |
|
MakeMyTrip Limited
F:MY1
|
Germany | €1.87 Billion |
|
Ningbo Orient Wires and Cables Co Ltd
SHG:603606
|
China | CN¥7.68 Billion |
|
Corporación Moctezuma S.A.B. de C.V
MX:CMOCTEZ
|
Mexico | MX$3.31 Billion |
Liability Composition Analysis (2023–2025)
This chart breaks down BillionToOne, Inc. Class A Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BLLN market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BillionToOne, Inc. Class A Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BillionToOne, Inc. Class A Common Stock (2023–2025)
The table below shows the annual total liabilities of BillionToOne, Inc. Class A Common Stock from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $152.55 Million | +13.58% |
| 2024-12-31 | $134.31 Million | -16.69% |
| 2023-12-31 | $161.20 Million | -- |
About BillionToOne, Inc. Class A Common Stock
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, an… Read more